Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
See Latest ArticlesPredictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open-angle glaucoma
Acta Ophthalmologica, 10/06/09
Martinez A et al. – Progression increased with lower DBP, lower MAP, antihypertensive medication, lower EDV in the OA and SPCA, and higher RI in the OA and SPCA. The risk for progression in patients treated with DT was half that in patients treated with BT.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09
Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09
Today in Glaucoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09
Natural History of Open-Angle Glaucoma
Ophthalmology, 10/28/09
Bevacizumab (Avastin) for the management of anterior chamber neovascularization and neovascular glaucoma
Clinical Ophthalmology, 11/23/09
Article Search
Sponsor